Archive for April 2022
Talaris Therapeutics and Greater Gift to Celebrate Clinical Trial Participants
WINSTON SALEM, NC – April 20 , 2022 – Talaris Therapeutics (Talaris), which is developing a new approach to induce immune tolerance in organ transplant recipients as well as patients…
Read More